Seroreactivity Against Lytic, Latent, and Possible Cross-Reactive EBV Antigens Appears on Average 10 Years Before MS-Induced Preclinical Neuroaxonal Damage
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage
J. Neurol. Neurosurg. Psychiatr. 2023 Oct 06;[EPub Ahead of Print], D Jons, V Grut, T Bergström, H Zetterberg, M Biström, M Gunnarsson, M Vrethem, N Brenner, J Butt, K Blennow, S Nilsson, I Kockum, T Olsson, T Waterboer, P Sundström, O AndersenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.